IMVT
Price
$16.39
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
2.75B
37 days until earnings call
IOVA
Price
$1.69
Change
-$0.09 (-5.06%)
Updated
Jun 27 closing price
Capitalization
564.35M
38 days until earnings call
Interact to see
Advertisement

IMVT vs IOVA

Header iconIMVT vs IOVA Comparison
Open Charts IMVT vs IOVABanner chart's image
Immunovant
Price$16.39
Change-$0.00 (-0.00%)
Volume$728
Capitalization2.75B
Iovance Biotherapeutics
Price$1.69
Change-$0.09 (-5.06%)
Volume$17.53M
Capitalization564.35M
IMVT vs IOVA Comparison Chart in %
Loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMVT vs. IOVA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Buy and IOVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IMVT: $16.10 vs. IOVA: $1.69)
Brand notoriety: IMVT and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 217% vs. IOVA: 125%
Market capitalization -- IMVT: $2.75B vs. IOVA: $564.35M
IMVT [@Biotechnology] is valued at $2.75B. IOVA’s [@Biotechnology] market capitalization is $564.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileIOVA’s FA Score has 1 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • IOVA’s FA Score: 1 green, 4 red.
According to our system of comparison, IMVT is a better buy in the long-term than IOVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 6 TA indicator(s) are bullish while IOVA’s TA Score has 3 bullish TA indicator(s).

  • IMVT’s TA Score: 6 bullish, 3 bearish.
  • IOVA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than IOVA.

Price Growth

IMVT (@Biotechnology) experienced а +1.90% price change this week, while IOVA (@Biotechnology) price change was -17.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IMVT is expected to report earnings on Aug 06, 2025.

IOVA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.75B) has a higher market cap than IOVA($564M). IMVT YTD gains are higher at: -35.002 vs. IOVA (-77.162). IOVA has higher annual earnings (EBITDA): -354.01M vs. IMVT (-437.78M). IMVT has more cash in the bank: 714M vs. IOVA (360M). IMVT has less debt than IOVA: IMVT (98K) vs IOVA (53.7M). IOVA has higher revenues than IMVT: IOVA (213M) vs IMVT (0).
IMVTIOVAIMVT / IOVA
Capitalization2.75B564M488%
EBITDA-437.78M-354.01M124%
Gain YTD-35.002-77.16245%
P/E RatioN/AN/A-
Revenue0213M-
Total Cash714M360M198%
Total Debt98K53.7M0%
FUNDAMENTALS RATINGS
IMVT vs IOVA: Fundamental Ratings
IMVT
IOVA
OUTLOOK RATING
1..100
6378
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
6394
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
27n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (23) in the Biotechnology industry is in the same range as IMVT (43) in the null industry. This means that IOVA’s stock grew similarly to IMVT’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IMVT (100) in the null industry. This means that IOVA’s stock grew similarly to IMVT’s over the last 12 months.

IOVA's SMR Rating (97) in the Biotechnology industry is in the same range as IMVT (97) in the null industry. This means that IOVA’s stock grew similarly to IMVT’s over the last 12 months.

IMVT's Price Growth Rating (63) in the null industry is in the same range as IOVA (94) in the Biotechnology industry. This means that IMVT’s stock grew similarly to IOVA’s over the last 12 months.

IMVT's P/E Growth Rating (100) in the null industry is in the same range as IOVA (100) in the Biotechnology industry. This means that IMVT’s stock grew similarly to IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTIOVA
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTWRX18.440.25
+1.37%
Templeton World R6
MXXVX36.550.39
+1.08%
Matthew 25
OAZMX160.481.14
+0.72%
Oakmark R6
SQCBX13.420.02
+0.15%
X-Square Balanced Fund, LLC C
DVIPX19.230.02
+0.10%
Davenport Value & Income

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-1.77%
ROIV - IMVT
62%
Loosely correlated
-1.81%
OCUL - IMVT
55%
Loosely correlated
-2.54%
CGON - IMVT
54%
Loosely correlated
-0.46%
IDYA - IMVT
52%
Loosely correlated
-4.13%
DNLI - IMVT
52%
Loosely correlated
-2.69%
More

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with PLX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then PLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-5.06%
PLX - IOVA
50%
Loosely correlated
+6.21%
ROIV - IOVA
44%
Loosely correlated
-1.81%
DNLI - IOVA
44%
Loosely correlated
-2.69%
CRSP - IOVA
43%
Loosely correlated
N/A
IMVT - IOVA
42%
Loosely correlated
-1.77%
More